India's Serum Institute delays vaccines for private sale in Bangladesh; focus on state campaigns

AstraZeneca has been embroiled in a dispute in Europe after it said it would have to cut supplies of its vaccine there in the first quarter.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MyLth5
via IFTTT